214 related articles for article (PubMed ID: 9565366)
1. Natural truncation of RANTES abolishes signaling through the CC chemokine receptors CCR1 and CCR3, impairs its chemotactic potency and generates a CC chemokine inhibitor.
Struyf S; De Meester I; Scharpé S; Lenaerts JP; Menten P; Wang JM; Proost P; Van Damme J
Eur J Immunol; 1998 Apr; 28(4):1262-71. PubMed ID: 9565366
[TBL] [Abstract][Full Text] [Related]
2. Diverging binding capacities of natural LD78beta isoforms of macrophage inflammatory protein-1alpha to the CC chemokine receptors 1, 3 and 5 affect their anti-HIV-1 activity and chemotactic potencies for neutrophils and eosinophils.
Struyf S; Menten P; Lenaerts JP; Put W; D'Haese A; De Clercq E; Schols D; Proost P; Van Damme J
Eur J Immunol; 2001 Jul; 31(7):2170-8. PubMed ID: 11449371
[TBL] [Abstract][Full Text] [Related]
3. Macrophage-derived chemokine induces human eosinophil chemotaxis in a CC chemokine receptor 3- and CC chemokine receptor 4-independent manner.
Bochner BS; Bickel CA; Taylor ML; MacGlashan DW; Gray PW; Raport CJ; Godiska R
J Allergy Clin Immunol; 1999 Mar; 103(3 Pt 1):527-32. PubMed ID: 10069890
[TBL] [Abstract][Full Text] [Related]
4. Monocyte chemotactic protein 3 is a most effective basophil- and eosinophil-activating chemokine.
Dahinden CA; Geiser T; Brunner T; von Tscharner V; Caput D; Ferrara P; Minty A; Baggiolini M
J Exp Med; 1994 Feb; 179(2):751-6. PubMed ID: 7507512
[TBL] [Abstract][Full Text] [Related]
5. LPS induces eosinophil migration via CCR3 signaling through a mechanism independent of RANTES and Eotaxin.
Penido C; Castro-Faria-Neto HC; Vieira-de-Abreu A; Figueiredo RT; Pelled A; Martins MA; Jose PJ; Williams TJ; Bozza PT
Am J Respir Cell Mol Biol; 2001 Dec; 25(6):707-16. PubMed ID: 11726396
[TBL] [Abstract][Full Text] [Related]
6. High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines.
Uguccioni M; Mackay CR; Ochensberger B; Loetscher P; Rhis S; LaRosa GJ; Rao P; Ponath PD; Baggiolini M; Dahinden CA
J Clin Invest; 1997 Sep; 100(5):1137-43. PubMed ID: 9276730
[TBL] [Abstract][Full Text] [Related]
7. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.
Yu X; Huang Y; Collin-Osdoby P; Osdoby P
J Bone Miner Res; 2004 Dec; 19(12):2065-77. PubMed ID: 15537451
[TBL] [Abstract][Full Text] [Related]
8. Differential activation of CC chemokine receptors by AOP-RANTES.
Elsner J; Mack M; Brühl H; Dulkys Y; Kimmig D; Simmons G; Clapham PR; Schlöndorff D; Kapp A; Wells TN; Proudfoot AE
J Biol Chem; 2000 Mar; 275(11):7787-94. PubMed ID: 10713092
[TBL] [Abstract][Full Text] [Related]
9. The CC chemokine antagonist Met-RANTES inhibits eosinophil effector functions through the chemokine receptors CCR1 and CCR3.
Elsner J; Petering H; Höchstetter R; Kimmig D; Wells TN; Kapp A; Proudfoot AE
Eur J Immunol; 1997 Nov; 27(11):2892-8. PubMed ID: 9394815
[TBL] [Abstract][Full Text] [Related]
10. HIV-specific T cell cytotoxicity mediated by RANTES via the chemokine receptor CCR3.
Hadida F; Vieillard V; Autran B; Clark-Lewis I; Baggiolini M; Debré P
J Exp Med; 1998 Aug; 188(3):609-14. PubMed ID: 9687538
[TBL] [Abstract][Full Text] [Related]
11. A chimeric MIP-1alpha/RANTES protein demonstrates the use of different regions of the RANTES protein to bind and activate its receptors.
Blanpain C; Buser R; Power CA; Edgerton M; Buchanan C; Mack M; Simmons G; Clapham PR; Parmentier M; Proudfoot AE
J Leukoc Biol; 2001 Jun; 69(6):977-85. PubMed ID: 11404385
[TBL] [Abstract][Full Text] [Related]
12. Differential regulation of eosinophil chemokine signaling via CCR3 and non-CCR3 pathways.
Sabroe I; Hartnell A; Jopling LA; Bel S; Ponath PD; Pease JE; Collins PD; Williams TJ
J Immunol; 1999 Mar; 162(5):2946-55. PubMed ID: 10072545
[TBL] [Abstract][Full Text] [Related]
13. RANTES and related chemokines activate human basophil granulocytes through different G protein-coupled receptors.
Bischoff SC; Krieger M; Brunner T; Rot A; von Tscharner V; Baggiolini M; Dahinden CA
Eur J Immunol; 1993 Mar; 23(3):761-7. PubMed ID: 7680615
[TBL] [Abstract][Full Text] [Related]
14. Monocyte chemotactic protein-2 (MCP-2) uses CCR1 and CCR2B as its functional receptors.
Gong X; Gong W; Kuhns DB; Ben-Baruch A; Howard OM; Wang JM
J Biol Chem; 1997 May; 272(18):11682-5. PubMed ID: 9115216
[TBL] [Abstract][Full Text] [Related]
15. Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody.
Heath H; Qin S; Rao P; Wu L; LaRosa G; Kassam N; Ponath PD; Mackay CR
J Clin Invest; 1997 Jan; 99(2):178-84. PubMed ID: 9005985
[TBL] [Abstract][Full Text] [Related]
16. Amino-terminally modified RANTES analogues demonstrate differential effects on RANTES receptors.
Proudfoot AE; Buser R; Borlat F; Alouani S; Soler D; Offord RE; Schröder JM; Power CA; Wells TN
J Biol Chem; 1999 Nov; 274(45):32478-85. PubMed ID: 10542293
[TBL] [Abstract][Full Text] [Related]
17. Characterization of functional chemokine receptors (CCR1 and CCR2) on EoL-3 cells: a model system to examine the role of chemokines in cell function.
Sarau HM; Rush JA; Foley JJ; Brawner ME; Schmidt DB; White JR; Barnette MS
J Pharmacol Exp Ther; 1997 Oct; 283(1):411-8. PubMed ID: 9336350
[TBL] [Abstract][Full Text] [Related]
18. The N-terminal extracellular segments of the chemokine receptors CCR1 and CCR3 are determinants for MIP-1alpha and eotaxin binding, respectively, but a second domain is essential for efficient receptor activation.
Pease JE; Wang J; Ponath PD; Murphy PM
J Biol Chem; 1998 Aug; 273(32):19972-6. PubMed ID: 9685332
[TBL] [Abstract][Full Text] [Related]
19. A small molecule antagonist of chemokine receptors CCR1 and CCR3. Potent inhibition of eosinophil function and CCR3-mediated HIV-1 entry.
Sabroe I; Peck MJ; Van Keulen BJ; Jorritsma A; Simmons G; Clapham PR; Williams TJ; Pease JE
J Biol Chem; 2000 Aug; 275(34):25985-92. PubMed ID: 10854442
[TBL] [Abstract][Full Text] [Related]
20. Aminooxypentane-RANTES induces CCR3 activation and internalization of CCR3 from the surface of human eosinophils.
Elsner J; Dulkys Y; Kimmig D; Wells TN; Proudfoot AE; Kapp A
Int Arch Allergy Immunol; 2001; 124(1-3):227-9. PubMed ID: 11306977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
